ReviewCancer metastasis reviews2026
Extracellular vesicles shape tumourigenesis: from signalling networks to systemic progression.
Review in Cancer metastasis reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extracellular vesicles (EVs) are established mediators of long-range intercellular communication in cancer, transferring oncogenic and regulatory cargo that reshapes recipient cells across tissues. Recent integrative multi-omics analyses of small EVs (sEVs) from healthy human donors consistently identify TSAP6/STEAP3 among the most abundant and reproducible sEV components, providing a physiological context for its role in sEV biology. Rather than acting solely as a downstream effector of p53, TSAP6 functions within a broader regulatory network by associating with TPT1/TCTP, which engages DDX3 and promotes the incorporation of RNAs, including microRNAs, into sEVs. The resulting p53-TSAP6-TCTP-DDX3 axis constitutes a wide-reaching regulatory system with non-cell-autonomous impact on cellular communication. Notably, TCTP sustains sEV-mediated signalling even in p53-mutant contexts. We suggest that these findings are consistent with other advances in cancer linking oncogenic transformation with EV biology. Together, these observations support regulated EV-mediated information transfer as a mechanism contributing to cancer progression and systemic cellular reprogramming. Conversely, reduction in EV abundance, altered cargo content, or signalling capacity may contribute to the activation of the tumour reversion programme in TCTP-dependent experimental models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.